Life Sciences Research for Lifelong Health

Pamela Lochhead

Pam’s interest in Signal Transduction started with her PhD in the MRC PPU, University of Dundee with Calum Sutherland studying insulin regulation of gene expression. She then moved to the Beatson Intitute for Cancer Research in Glasgow where she defined the activation mechanism of DYRKs and characterised somatic mutations in the ROCK protein kinases, with Vaughn Cleghon and Mike Olson. Keen to pursue her interest in signal transduction and cancer she was lured into the Signalling & Cell Fate ISP at the Babraham Institute, and is now investigating the role of ERK5 in cancer, whilst retaining an interest in DYRKs. Pam is enjoying the science, Simon’s tolerance of Scottish people and the climate, but misses the fine cuisine of her homeland! Outside work Pam enjoys spending time with her young daughter, cycling, cooking and embracing English culture.

Latest Publications

Visualisation of Endogenous ERK1/2 in Cells with a Bioorthogonal Covalent Probe.

Sipthorp J, Lebraud H, Gilley R

Bioconjugate chemistry
1520-4812: (2017)

PMID: 28449575

RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence.

Galloway A, Saveliev A, Łukasiak S

Science (New York, N.Y.)
352 1095-9203:453-9 (2016)

PMID: 27102483

Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation.

Lochhead PA, Clark J, Wang LZ

Cell cycle (Georgetown, Tex.)
15 1551-4005:506-18 (2016)

PMID: 26959608

Maternal DNA Methylation Regulates Early Trophoblast Development.

Branco MR, King M, Perez-Garcia V

Developmental cell
36 1878-1551:152-63 (2016)

PMID: 26812015

MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road.

Caunt CJ, Sale MJ, Smith PD

Nature reviews. Cancer
15 1474-1768:577-92 (2015)

PMID: 26399658

Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome.

Ashford AL, Dunkley TP, Cockerill M

Cellular and molecular life sciences : CMLS
1420-9071: (2015)

PMID: 26346493